Position in ZTS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,683,831
+$174,058 QoQ
Shares Held
51,264
+72.7% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#395
of 1,409 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Advisors Asset Management, Inc. holds $29,351,232 across 10 Drug Manufacturers - Specialty & Generic names. ZTS ranks #3 (12.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
885,796 | $14,066,440 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
12,119 | $6,566,437 | |
| 3 | ZTS |
Zoetis Inc.
This page
|
51,264 | $3,683,831 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
17,488 | $2,947,427 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
24,884 | $843,069 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
24,309 | $389,673 | |
| 7 | ALKS |
Alkermes plc.
|
7,425 | $389,070 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
23,253 | $336,935 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,683,831 | 51,264 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,509,773 | 29,691 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,772,695 | 22,037 | Shares | Sole | 2026-08-21 | |
| 2025-09-30 | $2,249,084 | 15,371 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,458,083 | 15,762 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,656,133 | 16,132 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,215,097 | 19,733 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $3,423,057 | 17,520 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $2,970,003 | 17,132 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,735,787 | 16,168 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,057,261 | 15,490 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,640,320 | 15,176 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,426,266 | 14,089 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,175,703 | 13,072 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,784,596 | 19,001 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,432,023 | 23,144 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $3,874,744 | 22,542 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $3,950,394 | 20,947 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $4,874,987 | 19,977 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $2,450,046 | 12,620 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,128,417 | 11,421 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $1,831,649 | 11,631 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $1,772,505 | 10,710 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,791,949 | 10,836 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,490,153 | 18,171 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $2,007,320 | 17,056 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||